Recent Finacing
Recent Raise
US-based biotech developing an oral therapy for Duchenne muscular dystrophy, advancing preclinical development and manufacturing after demonstrating improved muscle strength, regeneration, and reduced inflammation and fibrosis in mdx models.
Recent Investors
Funding round
Investor